Clinical Trials Directory

Trials / Completed

CompletedNCT04710771

Effect of Prone Positioning in Patients With COVID-19

Effect of Prone Positioning and Alternate Nostril Breathing Technique in Patients With COVID-19: A Quasi Experimental Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Sialkott College of Physical Therapy · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

COVID-19 is affecting the people around the world and the infected individuals' may either stay asymptomatic or present to hospitals with severe distress and life threatening symptoms. The objective of the study is to investigate role of Prone positioning and alternate nostril breathing in patients with Covid-19.

Detailed description

In this quasi experimental study, 30 patients aged 40-80 years of either gender with a confirmed diagnosis of COVID-19 receiving supplemental oxygen were recruited from DHQ Hospital Faisalabad. patients were grouped into two A \& B. We collected baseline data on demographics and anthropometrics. After baseline data collection, all the patients were helped into the prone position, which was maintained for a minimum duration of three hours. After that patients in group B performed alternate nostril breathing for 10 minutes with help of physiotherapist. Clinical data were re-collected on 3rd day of intervention one hour after returning to the supine position in group A and after alternate nostril breathing in group B. The main study outcome was the variation in oxygenation (partial pressure of oxygen \[PaO2\]/ fractional concentration of oxygen in inspired air \[FiO2\]) between baseline and resupination, and General psychological state through GAD-7 General anxiety disorder questionnaire.

Conditions

Interventions

TypeNameDescription
OTHERProne Lying Positionpatient lies on his/ her stomach facing floor.
OTHERalternate nostril breathingpatient inspires with one nostril at a time, right or left one by one and expires by mouth.

Timeline

Start date
2020-11-23
Primary completion
2021-01-15
Completion
2021-01-29
First posted
2021-01-15
Last updated
2025-05-15

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT04710771. Inclusion in this directory is not an endorsement.